University of Florida Researchers Unlock New Frontiers in Brain Tumor Treatments
Researchers at the University of Florida’s are making breakthroughs in the treatment of malignant brain tumors. Duane Mitchell, M.D., Ph.D., co-directs the teams conducting this research at the Preston A. Well Jr. Center for Brain Tumor Therapy at UF Health. Over the past ten years, the center has received FDA approval on 12 therapeutics and launched 13 novel immunotherapy clinical trials.
UF Nursing Researchers Provide Parents CHOICES for Reproductive Health
Two University of Florida College of Nursing researchers earned a four-year $3 million grant to support a large national study to test the effect of a web-based educational tool that aims to help young adults understand sickle cell disease — or even prevent it from being inherited.
The V Foundation Announces Renewed Research Support for UF’s Dr. Duane Mitchell
During the 16th annual Dick Vitale Gala, the V Foundation for Cancer Research announced that Duane Mitchell, M.D., Ph.D., director of the UF Clinical and Translational Science Institute, assistant vice president for research at UF and co-leader of the UF Health Cancer Center’s Cancer Therapeutics & Host Response research program, will receive additional support for his research on brain cancer in children.
UF College of Medicine Announces Clinical Science and Basic Science Faculty Research Awards
Michael Okun, MD, and Jiang Bian, Ph.D., were recently announced as the winners of the 2021 College of Medicine Clinical Science Research Award and the UF College of Medicine Basic Science Research Award, respectively.
UF Anticancer Drug Receives FDA Clearance for Clinical Trials
An anticancer drug developed by researchers from the University of Florida College of Pharmacy has become the first drug of its kind allowed to proceed to clinical trial by the U.S. Food and Drug Administration.
UF Researchers Discover Marine Natural Product off Florida’s Coast That Could Help Fight Cancer
University of Florida researchers have discovered a novel marine natural product that binds to a new site of tubulin, an important target for cancer drugs.
UF Health Virtual Human Intervention Allows for Colorectal Cancer Screening From Home
A new University of Florida Health intervention gives patients who qualify access to colorectal cancer screening information and tests from the comfort of their own homes.
National Effort to Hasten Treatments for Those With Pancreatic Cancer Enrolling Patients at UF Health
A novel clinical trial platform that aims to accelerate treatment discoveries for people battling pancreatic cancer is now enrolling patients at 15 sites nationwide, including the University of Florida Health Cancer Center. An initiative of the national nonprofit organization Pancreatic Cancer Action Network, or PanCAN, Precision PromiseSM began development in 2016. The UF Health Cancer Center is the […]
Dr. Chengguo Xing’s Kava Clinical Study Makes the Cover of Cancer Prevention Research
Kava’s reputation in preventing cancer just received a boost from the American Association for Cancer Research. The May 2020 cover of the organization’s flagship journal, Cancer Prevention Research, featured a clinical study on kava led by Chengguo “Chris” Xing, Ph.D., a professor of medicinal chemistry and the Frank A. Duckworth Eminent Scholar Chair in the UF […]
UF Researchers Discover Breakthrough Anticancer Drug
Researchers from the University of Florida College of Pharmacy have discovered a safer and more effective anticancer drug to target leukemia, lymphoma, and breast and lung cancers. The journal Nature Medicine published the findings. Known as DT2216, the drug acts on a protein called B-cell lymphoma-extra large, or BCL-XL, which fuels the growth of malignant […]